Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
10.63
-1.88 (-15.03%)
Sep 17, 2025, 4:00 PM EDT - Market closed

Neuphoria Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover Neuphoria Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $28, which forecasts a 163.41% increase in the stock price over the next year. The lowest target is $21 and the highest is $35.

Price Target: $28 (+163.41%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$21$28$35$35
Change+97.55%+163.41%+229.26%+229.26%

Analyst Ratings

The average analyst rating for Neuphoria Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJun '25Jul '25Aug '25Sep '25
Strong Buy1112
Buy0000
Hold0000
Sell0000
Strong Sell0000
Total1112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Strong Buy
Maintains
$18$35
Strong BuyMaintains$18$35+229.26%Sep 11, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$21
Strong BuyReiterates$21+97.55%Aug 26, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$8$21
Strong BuyMaintains$8$21+97.55%Feb 4, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
1.96M
EPS This Year
-11.73
from -0.01
EPS Next Year
-0.70
from -11.73
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2025
Period EndingJun 30, 2020Jun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2025
Revenue
2.07M695.81K4.17M---1.96M
Revenue Growth
-59.99%-66.32%499.60%----
EPS
-0.01-0.01-0.01-0.01-0.01-11.73-0.70
EPS Growth
-------
Forward PE
-------
No. Analysts
-----34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025
High2.0M
Avg2.0M
Low1.9M

Revenue Growth

Revenue Growth2025
High-
Avg-
Low-

EPS Forecast

EPS2025
High-0.44
Avg-0.70
Low-0.94

EPS Growth

EPS Growth2025
High-
Avg-
Low-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.